full issue - Association of Biotechnology and Pharmacy
full issue - Association of Biotechnology and Pharmacy
full issue - Association of Biotechnology and Pharmacy
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Current Trends in <strong>Biotechnology</strong> <strong>and</strong> <strong>Pharmacy</strong>Vol. 5 (2) 1084-1097 April 2011. ISSN 0973-8916 (Print), 2230-7303 (Online)1089Insulin release (%)PLGA 50:50 (EtAc:ESE)PLGA 50:50 (DCM:ESE)PLGA 50:50 (MPEG:MM)Insulin release (%)pH 1.2pH 5.6pH 7.4Time (hr)Fig. 2. Insulin release (%) from nanoparticles prepared bydifferent methods in phosphate buffer pH 7.4 at 37 0 C Datarepresented as the mean+SD (n=3)84% entrapment efficiency (EE) as shown inTable 1. Of the different methods <strong>of</strong> preparation,MM method resulted in lower EE%. However,there was no significant difference in Insulin EE%compared to nanoparticles prepared by ESEmethods (p>0.05). All nanoparticles prepared bydifferent methods showed negative zeta potentialat pH 7.4.Insulin Release from nanoparticles preparedby different methods : The release <strong>of</strong> insulinfrom nanoparticles prepared by different methodswas found to be biphasic (Fig. 2). The initial rapidrelease (burst effect) was high, where, 52%, 52.4,<strong>and</strong> 54.2% <strong>of</strong> the entrapped insulin was releasedfrom nanoparticles prepared by ESE (DCM),MM, ESE (ET-AC), respectively. This burstrelease in the first 5 minutes was followed byabout 8% release <strong>of</strong> insulin after 30 minutes incase <strong>of</strong> ESE (DCM) <strong>and</strong> MM methods. On theother h<strong>and</strong>, about 16% <strong>of</strong> insulin was releasedfrom nanoparticles <strong>of</strong> ESE (ET-AC) methodfollowing the burst release. After the first 30minutes, very slow release <strong>of</strong> minute amounts <strong>of</strong>insulin was observed over 24 hours.To use nanoparticles via the oral route, itis important to test the release <strong>of</strong> insulin atdifferent pH range. Insulin release fromnanoparticles <strong>of</strong> ESE (DCM) method wasselected for the test as they show no significantdifferences in release compared to MM method(P>0.05). The release <strong>of</strong> insulin was significantlyFig. 3. Effect <strong>of</strong> release medium pH on insulin release fromPLGA (50:50) nanoparticles prepared using ESE (DCM)method. Data represented as the mean+ SD. (n=3).affected by the external pH. Complete release<strong>of</strong> insulin occurred in 5 minutes at pH 1.2 asshown in Figure 3. However, the initial burstrelease was only 8% at pH 5.6 <strong>and</strong> 52% at pH7.4. After 24 hours, only 42.5% <strong>of</strong> insulin wasFig. 4. MALDI-TOF Mass spectra <strong>of</strong> st<strong>and</strong>rd insulin (a<strong>and</strong> e), insulin extracted from nanoparticles prepared usingMM (b), ESE (ET-AC) (c), <strong>and</strong> ESE (DCM) (d) methods.Insulin concentration used was 0.2 mg/ml.Insulin immunogenicity (%)Time (hrs)Mass/ChargeESE (DCM) ESE (ET-AC) MMFig. 5. Immunogenicity <strong>of</strong> insulin, determined as the ratio<strong>of</strong> insulin detected by ELISA test to insulin detected byBCA protein assay kit.Mahmoud et al